Answers are grounded in this paper and cite their sources.
Metabolic diseases (MD) are amenable to network-based modeling frameworks, given the systemic perturbations induced by disrupted molecular mechanisms. We present here a brief overview of network modeling methods applied to inborn errors of metabolism (IEM), systemic metabolic conditions (mainly diabetes), and metabolism-related inflammation and autoimmune disorders. Clinical diagnosis and identification of causal agents in IEMs and uncovering the multifactorial mechanisms underlying the development of diabetes and other systemic metabolic diseases are the main challenges being addressed. The review also highlights some of the studies undertaken to investigate the role of the gut microbiome in MD, especially in diabetes. While the network frameworks employed in different modeling approaches have provided novel insights, some technique-specific limitations and overall gaps in general research trends need further attention.
No takes yet. Share an insight, caveat, or question.
Badkas et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: